EP3820573
3-(5-Hýdroxý-1-oxóísóindólín-2-ýl)píperidín-2,6-díón-afleiður og notkun á þeim við meðhöndlun á ÍKAROS-fjölskyldu sinkfingurs-2 (IKZF2)-háðum sjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.7.2019EP published:
9.8.2023EP application number:
19782691.0
EP translation filed:
25.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
7.7.2039Expiry date:
7.7.2026Next due date:
31.7.2026
Title in English:
3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASESLanguage of the patent:
English
Timeline
Today
8.7.2019EP application
9.8.2023EP Publication
25.10.2023Translation submitted
15.11.2023Registration published
7.7.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
ADCOCK, ClaireAddress:
Cambridge, Massachusetts 02139, US
Name:
BONAZZI, SimoneAddress:
Cambridge, Massachusetts 02139, US
Name:
CERNIJENKO, ArtiomAddress:
Cambridge, Massachusetts 02139, US
Name:
LAM, PhilipAddress:
Cambridge, Massachusetts 02139, US
Name:
LINKENS, Kathryn TaylorAddress:
Cambridge, Massachusetts 02139, US
Name:
MALIK, Hasnain AhmedAddress:
Cambridge, Massachusetts 02139, US
Name:
THOMSEN, Noel Marie-FranceAddress:
Cambridge, Massachusetts 02139, US
Name:
VISSER, Michael ScottAddress:
Cambridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862695920 PDate:
10.7.2018Country:
US
Number:
201962835543 PDate:
18.4.2019Country:
US
Classification
Categories:
A61P 35/00, C07D 401/04, C07D 401/14, A61K 31/454
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.6.2024
Expires: 7.7.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 4.7.2025
Expires: 7.7.2026
Payer: Árnason Faktor ehf.